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Background: Incidental white matter hyperintensities (WMHs) are common findings on T2-weighted magnetic
resonance images of the aged brain and have been associated with cognitive decline. While a variety of
pathogenic mechanisms have been proposed, the origin of WMHs and the extent to which lesions in the deep and
periventricular white matter reflect distinct etiologies remains unclear. Our aim was to quantify the fractional blood
volume (vb) of small WMHs in vivo using a novel magnetic resonance imaging (MRI) approach and examine the
contribution of blood–brain barrier disturbances to WMH formation in the deep and periventricular white matter.
Methods: Twenty-three elderly volunteers (aged 59–82 years) underwent 7 Tesla relaxographic imaging and
fluid-attenuated inversion recovery (FLAIR) MRI. Maps of longitudinal relaxation rate constant (R1) were prepared
before contrast reagent (CR) injection and throughout CR washout. Voxelwise estimates of vb were determined by
fitting temporal changes in R1 values to a two-site model that incorporates the effects of transendothelial water
exchange. Average vb values in deep and periventricular WMHs were determined after semi-automated segmentation
of FLAIR images. Ventricular permeability was estimated from the change in CSF R1 values during CR washout.
Results: In the absence of CR, the total water fraction in both deep and periventricular WMHs was increased
compared to normal appearing white matter (NAWM). The vb of deep WMHs was 1.8 ± 0.6 mL/100 g and was
significantly reduced compared to NAWM (2.4 ± 0.8 mL/100 g). In contrast, the vb of periventricular WMHs was
unchanged compared to NAWM, decreased with ventricular volume and showed a positive association with
ventricular permeability.
Conclusions: Hyperintensities in the deep WM appear to be driven by vascular compromise, while those in the
periventricular WM are most likely the result of a compromised ependyma in which the small vessels remain
relatively intact. These findings support varying contributions of blood–brain barrier and brain-CSF interface
disturbances in the pathophysiology of deep and periventricular WMHs in the aged human brain.
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White matter hyperintensities (WMHs) are commonly ob-
served in the elderly brain on T2- weighted and proton
density magnetic resonance imaging (MRI). The preva-
lence and severity of lesions increases with age and even
mild increases in WMH volume may diminish cognition
and global function in later life [1,2]. The presence of* Correspondence: andersov@ohsu.edu
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unless otherwise stated.WMHs has been associated with a number of disease states
in the elderly, including stroke and dementia. In patients
with Alzheimer’s disease, WMH severity is often related to
deficits in attention and frontal executive functions, leading
to the suggestion that WMHs, in combination with amyl-
oid deposition, may provide a ‘second hit’ to the degenerat-
ing brain, increasing the risk and/or clinical expression of
the disease [3].
The etiology of incidental WMHs in the elderly is
poorly understood. While neuropathological studies are
informative, the myelin disruption, gliosis, and edemaral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Subject characteristics (N = 20)a
Characteristic
Female, male 8, 12
Age, y 71 ± 6
Education, y 17 ± 3
Hypertension, hyperlipidemiab 3, 5
MMSE 28 ± 2
Total homocysteine, μmol/L 10.8 ± 1.8




aMean (SD) or median (range), unless otherwise noted; bNumber treated; cICV,
intracranial volume; dFazekas visual rating scale.
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multiple inflammatory, neurodegenerative, and ischemic
processes. In addition, the extent of these features varies
with lesion severity, further obscuring the underlying
mechanisms of their formation [4]. By and large, though,
WMHs are a prominent feature of small vessel disease.
Moreover, the severity of lesions is often associated with
hypertension, diabetes, and hypercholesterolemia, provid-
ing additional support for the role of blood–brain barrier
disturbances in their pathogenesis [5,6]. However, accu-
mulating evidence suggests that the contribution of vascu-
lar factors to WMH formation may differ in the deep
compared to the periventricular WM. In contrast to deep
lesions (dWMHs), periventricular WMHs (pWMHs) are
generally independent of infarct prevalence and plasma
homocysteine levels, and show inconsistent association
with hypertension and systolic blood pressure, especially
in their early stages [7-11]. Moreover, histology regularly
reveals defects in the adjacent ependymal lining suggesting
that cerebrospinal fluid (CSF) infiltration may play a par-
ticularly important role in pWMH formation [12].
In recent years, quantitative MRI techniques have
confirmed many of the histopathological features of
WMHs in vivo, including myelin disruption (decreased
magnetization transfer ratio) [13] and Wallerian degen-
eration (reduced fractional anisotropy) [14]. In addition,
arterial spin labeling [15,16] and dynamic susceptibility
contrast (DSC) MRI [17] have demonstrated WMH
perfusion deficits compared to normal appearing white
matter (NAWM). To extend these findings, we used T1
relaxographic imaging to measure the fractional blood
volume (vb) of small, focal WMHs in the deep WM
(centrum semiovale) and in mild hyperintense periven-
tricular linings and caps. Relaxographic imaging is
based on the measurement of the longitudinal relax-
ation rate constant of water protons (R1 ≡ 1/T1) before
and after addition of a paramagnetic contrast reagent
(CR). In cell suspensions and excised tissue, the technique
provides information about intra- and extracellular vol-
ume and water residence times [18]. In combination with
spatial encoding, the approach provides a quantitative
measure of water exchange dynamics at the brain barriers.
Relaxographic imaging has now been applied to a variety
of human pathologies, including osteosarcoma, breast car-
cinoma, and multiple sclerosis [19-21].
Here, we measured R1 values throughout the brain be-
fore CR injection and during washout in a group of elderly
adults with minimal cerebrovascular risk factors. Absolute
values of vb were then obtained by fitting the time-course
of tissue R1 changes to a pharmacokinetic model that
incorporates the effects of water exchange between the
blood and extravascular compartments. Next, we seg-
mented hyperintense from normal-appearing WM on
fluid-attenuated inversion recovery (FLAIR) images andquantified the vb in dWMHs and pWMHs on co-
registered vb maps. Finally, to investigate the potential role
of degenerative factors and permeability changes at the
ventricular CSF-tissue interface on pWMH formation, we
examined the association of pWMH vb with ventricular
volume and with the rate of CR leakage into the CSF.
Methods
Participants
Twenty-three elderly individuals in good general health
were enrolled. All participants underwent complete
neurological and neuropsychological evaluation and pro-
vided a non-fasting blood sample for analysis of plasma
homocysteine levels by fluorescence polarization im-
munoassay [22]. Subjects were excluded with body mass
index greater than 30 kg/m2, uncontrolled hypertension,
or history of diabetes mellitus, cardiovascular disease or
TIA/stroke. Ten subjects were diagnosed with mild cog-
nitive impairment (MCI) based on research criteria [23].
These individuals satisfied all criteria for study inclusion
but had lower Mini-Mental State Examination (MMSE)
[24] scores than cognitively normal subjects (26 ± 2 and
29 ± 1, respectively; P = .01). Three participants showed
no radiographic evidence of WMHs, leaving a total of 20
datasets for analysis. Demographic features of these par-
ticipants are shown in Table 1. The study was approved
by the Oregon Health & Science University Institutional
Review Board and all volunteers signed written informed
consent.
MRI data acquisition
All images were acquired using a 7 Tesla Magnetom scan-
ner (Siemens Healthcare, Erlangen, Germany) with 8- or
24-channel transmit/receive head coil. High-resolution in-
version recovery magnetization prepared rapid acquisition
gradient echo (MPRAGE) [inversion time (TI) = 1050 ms,
repetition time (TR) = 2300 ms, echo time (TE) = 2.8 ms,
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reconstruction matrix = 320 × 320 pixels, and slice thick-
ness = 0.8 mm] and FLAIR, [TE = 386 ms, TI = 2150 ms,
TR = 8000 ms, FOV= 224 × 256 mm2, matrix = 280 × 320,
slice thickness = 0.8 mm] images were used for volumetric
measurements and WMH segmentation. The nominal
spatial resolution of both sequences was 0.8 mm3. Dual
T2- and proton density-weighted turbo spin echo with
TE = 11 and 87 ms, TR = 10000 ms, FOV = 168 × 224
mm2, matrix = 256 × 192 mm2, slice thickness = 2 mm
with 2 mm interslice gap were also obtained.
Variable inversion time MPRAGE datasets were ac-
quired for T1-relaxography. Each dataset consisted of
four axial MPRAGE images with TI = 300, 1800, or
3200 ms, or with no inversion pulse. Other sequence
parameters were: TE = 2.3 ms, TR = 3500 ms, FA = 6°,
FOV = 176 × 256 mm2, matrix = 176 × 256 pixels, slice
thickness = 2 mm, resulting in a nominal spatial reso-
lution of 1 × 1 × 2 mm3. All images were centered on
the lateral ventricles, oriented parallel to the anterior
commissure-posterior commissure line. MPRAGE data-
sets were acquired prior to a 0.11 mmol/kg dose of
intravenous CR (gadoteridol; Bracco Diagnostics,
Princeton, NJ, USA) and throughout the subsequent
50–60 minute washout period. The acquisition time for
each dataset was 14.5 min.Figure 1 Data workflow: (Left, top) FLAIR images were linearly register
(Left, lower) Co-registered R1 maps were prepared in high-resolution MPRA
1800 image collected at the temporal mid-point of CR washout (see Metho
pWMHs and dWMHs and corresponding FLAIR image. Insets show a magn
The vb histograms of each WMH are also shown.Image processing and analysis
An overview of the image analysis procedure is shown in
Figure 1. Binary masks of NAWM and CSF were pre-
pared using FMRIB’s Software Library (FSL; http://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/). Technical details of FSL
image analysis tools have been described and validated
previously [25]. Briefly, high-resolution MPRAGE im-
ages underwent bias correction [26], brain extraction
(with eye and optic nerve cleanup) [27] and 3-class seg-
mentation [28]. Use of default segmentation parameters
resulted in exclusion of WMHs (which appear relatively
hypointense on T1-weighted images) from the WM seg-
ment. NAWM masks were prepared as a subset of all
WM voxels within 15 (±3) mm of the superior surface
of the lateral ventricles. Ventricular CSF masks were
prepared by manual removal of parenchymal pixels from
the CSF binary image. CSF volume was calculated using
partial volume estimates and normalized to the total
intracranial volume. Binary WMH masks were prepared
after linear registration (6 degrees of freedom) [29] of
skull-stripped FLAIR images to high resolution MPRAGE
space followed by segmentation of WMHs based on man-
ual seeding and k-nearest-neighboring clustering (Seg3D;
http://www.sci.utah.edu). Individual dWMH and pWMH
masks were prepared by an experienced investigator.
Careful attention was paid to avoid fluid-filled boundariesed to high-resolution MPRAGE space using rigid body registration.
GE space after alignment of all variable-TI MPRAGE images to the TI
ds for additional details). (Right) Fractional blood volume (vb) maps of
ified view of the WMHs (outlined in white) with associated color scales.
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pear on at least three consecutive slices in all three orien-
tations were not included. In 15 subjects, masks were
independently prepared by a second trained investigator.
Based on a 79 and 84% pixel overlap of dWMHs and
pWMHs, respectively, we estimate segmentation reprodu-
cibility to be approximately 80%.
The severity of WMHs was assessed using the Fazekas
rating scale [30]. WMHs were defined as WM areas with
increased signal intensity on T2-spin echo and FLAIR
images. Special care was taken to distinguish WMHs
from lacunar infarcts, defined as parenchymal defects
not extending to the cortical gray matter with a signal
intensity following that of the CSF on all pulse se-
quences [31]. WMHs were present in all subjects; 15
participants had lesions in both deep and periventricular
WM. In 17/20 subjects, lesions were seen as small scat-
tered hyperintensities or as caps and pencil-thin linings
around the ventricles (≤grade 1). In the remaining sub-
jects, WMHs (3 periventricular, 3 deep) were more nu-
merous and included a few patchy or more diffuse
lesions. These were rated as grade 2. The total volume
of pWMHs and dWMHs was 3.0 (±2.9) and 0.55 (±0.49)
mL, respectively.
Pharmacokinetic analysis
R1 maps were prepared from variable inversion time
MPRAGE datasets. After brain extraction, all images in
the dataset collected midway through CR washout (ap-
proximately 30 min post-CR) were linearly registered to
the TI 1800 MPRAGE image. Each image in the remaining
datasets was then registered to one of these images by ap-
plication of the TI-dependent transform. R1 maps were
prepared from each dataset by nonlinear least squares
curve fitting (IDL; ITT Visual Information Solutions,
Boulder CO, USA) of the signal intensity at each inversion
time to the MPRAGE signal equation that includes
magnetization losses due to sampling during recovery
[32]. After preparation, all R1 maps were linearly regis-
tered to high-resolution MPRAGE space.
Full volume vb maps were prepared by voxelwise fit-
ting of water proton R1 values before and at each time
after CR administration to a two-site (blood, extravascu-
lar) tissue model that accounts for the effects of transen-
dothelial water exchange. The model assumes that each
voxel exhibits monoexponential recovery after inversion
and that CR remains confined to the intravascular space
(i.e., Ktrans, the rate constant for CR extravasation, is
negligible). Since tissue water molecules exchange across
the capillary walls, the measured R1 value of tissue is a
function of the relaxation behavior of water protons in
each compartment. Due to the short range of the inter-
actions responsible for longitudinal relaxation quenching
by CR (typically on the order of several nanometers),only the R1 of blood is increased by an intravascular CR;
the R1 of water protons in the extravascular space is un-
affected. Therefore, the observed relaxation behavior of
tissue becomes a function of the R1 value in the blood
and the rate at which water exchanges across the capil-
lary wall [33]. Under these conditions, it has been shown
that the R1 behavior of water protons in tissue during
CR washout from the blood, R1t(t), can be described by
Eq. (1) where R1b(t) is the longitudinal relaxation rate
constant of intravascular water at time t, R1t(0) and R1b
(0) are the R1 values in tissue and blood before CR ad-
ministration, and τb
−1 is the rate constant for water ex-
travasation [33,34]. fw is a scaling factor that accounts
for the restricted localization of CR to the blood plasma.
R1e is the rate constant for extravascular water relaxation
in the absence of exchange and is given by Eq. (2).
R1t tð Þ ¼ 12
(
















where R1e ¼ R1t 0ð Þ−R1b 0ð Þ  vb=f wð Þ1−vb=f w
 
ð2Þ
Values of vb were iteratively determined using a
gradient-expansion, non-linear least-squares algorithm
[35] with τb and fw held constant at reasonable values
(0.3 and 0.8 s, respectively) [36,37]. R1b(t) values were
measured from a region of interest contained entirely
within the sagittal sinus. Uncertainties in R1 and vb
values were estimated using a Monte Carlo approach.
The signal-to-noise ratio (SNR) of each MPRAGE image
was calculated using the signal-background method [38].
Noise was then added by randomly sampling a Gaussian
distribution with mean = 0 and standard deviation = sig-
nal intensity/SNR. Several voxels in each variable-TI
dataset corresponding to WMHs were randomly selected
and R1t values estimated 1000 times. R1t values were
found to be robust to noise, with the variance in all vox-
els <0.04%. Errors in vb were estimated by randomly
selecting R1(t) values within 1 standard deviation of the
mean and fitting to Eq. (1), as described above. Based on
1000 simulations, we estimate vb variance to be approxi-
mately 1-2% of the mean.
Ventricular permeability
Ventricular permeability was assessed based on region of
interest (ROI) analysis of the temporal changes in CSF R1
Figure 2 Relationship between R1t and R1b values in a dWMH
(circle) and pWMH (square) voxel (shown at far right). Curves
represent the best fit of the data in each WMH to Eq. (1). Error bars
(±SD) are based on Monte Carlo simulations (see text). Upper axis
represents plasma CR concentration, as calculated from Eq. (3).
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were defined in the posterior horns of the lateral ventricles
on R1(t) maps. To minimize partial volume errors, ROIs
were selected in areas that afforded optimal conspicuity of
CSF-tissue interfaces. In the majority of cases, this was in
the left posterior horn. Pixels with estimated fractional
CSF volumes less than 1 were excluded to further reduce
partial volume contamination.
Statistical analyses
Data analysis was performed in Stata (StataCorp, College
Station, TX, USA). Distributional outliers were identified
by Mahalanobis and Cook’s Distance methods [39]. The
mean vb of WMH voxels was determined by fitting to a
Gaussian distribution. Distributions that could not be
normalized by common transformations (N = 3) were fit
to non-negative, bounded (gamma or Weibull) distribu-
tions using EasyFit (Mathwave Technologies, Spokane,
WA, USA). Voxels with nonphysiological vb values (i.e.,
less than 0 or greater than 20 mL/100 g) were excluded
from analysis. On average, these voxels accounted for 29
and 34% of all dWMH and pWMH voxels, respectively.
Univariate associations were examined using linear re-
gression analysis and the coefficient of determination, r2.
Regional differences were examined using one-way
within subject ANOVA with WM type (pWMH,
dWMH, or NAWM) as the independent variable. P
values < .05 were considered significant in statistical
tests. Post-hoc pairwise comparisons were tested using
paired t-tests. A modified Bonferroni procedure was
used to adjust the level for (two-tailed) significance test-
ing [40].
Results
In the absence of CR, the average (±standard deviation)
longitudinal relaxation time (T1 ≡ R1
−1) of NAWM was
1454 (±54) ms. T1 values depend on field strength and
vary somewhat with sequence and post-processing de-
tails. Nevertheless, this value corresponds well with the
1220 (±36) ms reported by Rooney and colleagues [41]
and the 1500 (±100) ms reported by Li and Deoni [42].
Compared to NAWM, T1 times were increased in both
pWMHs and dWMHs (1861 ± 124 ms and 1608 ±
80 ms, respectively; P < .0001). To our knowledge, T1
values of WMHs at 7Tesla have not been reported previ-
ously. Nevertheless, the 10-28% increase in WMH T1
values compared to NAWM measured here is consistent
with the 5-40% increase in WMH T1 times noted at
lower field strengths [43,44]. T1 values were significantly
larger in pWMHs than dWMHs (P < .0001), although
the between-subject variance was also increased in the
former, most likely due to increased partial volume ef-
fects. Assuming a linear dependence of R1 values on tis-
sue water fraction [45] and that T1 differences are duesolely to alterations in water content, this corresponds
to roughly a 15% increase in the total water fraction of
pWMHs compared to dWMHs. Associations of WMH
T1 values with age, gender, memory complaint (present
or absent) and homocysteine levels were not significant.
As expected, R1t values increased after CR administra-
tion in all subjects. Figure 2 shows the R1t behavior in a
representative dWMH and pWMH voxel plotted against
the R1b values. The best fit of the data in each voxel to
Eq. (1) is also shown. The concentration of CR in plasma
([CRp]) depends on R1b [19] as:
R1b ¼ R1b 0ð Þ þ r1 1−hð Þ CRp
  ð3Þ
where h is the microvascular hematocrit (ca. 0.40) [46]
and r1 is the relaxivity of CR at 7 T (3.3 s
−1 mM−1 for
gadoteridol) [47] and is plotted along the upper axis.
The nonlinear relationship between R1t and [CRp] ob-
served here (especially prominent in pWMHs) is consist-
ent with the compartmental nature of tissue and the
restricted exchange of water between blood and extra-
vascular sites.
The mean vb values in NAWM averaged 2.4 (±0.6)
mL/100 g, in good agreement with the 2.0 (±0.4) mL/
100 g measured by DSC MRI [48] and the 2.7 (±0.4)
mL/100 g found by two-point T1 relaxography in healthy
adults [49]. In dWMHs and pWMHs, vb averaged 1.8
(±0.6) and 2.4 (±0.8) mL/100 g, respectively. Mean vb
values varied significantly between dWMHs, pWMHs
and NAWM (F2,14 = 6.33, P = .0054). Post-hoc tests
showed a significant reduction in the vb of dWMHs
compared to NAWM (P < .0001). After correcting for
multiple comparisons, differences between pWMHs and
dWMHs were not significant (P = .033). Similarly, no
significant associations of vb with age, gender, or mem-
ory complaint were observed in periventricular or deep
WMHs.
Figure 4 Linear regression plots of pWMH vb and (a) percent
change in CSF R1 values 33 (±4) minutes after CR administration,
and (b) ventricular volume, as a percentage of the total
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(±0.023) s−1, in good agreement with the 0.231- 0.237 s−1
reported previously [41,50]. These values increased to
0.244 (± 0.022) s−1 within 13 (±5) minutes after CR ad-
ministration and continued to increase with time (F3,18 =
8.71, P < .0001). Figure 3 shows the R1 histograms of ven-
tricular CSF during CR washout. The total change in R1
values over the 50–55 minute measurement period
was 0.0091 (±0.01) s−1. Assuming a linear dependence
of CSF R1 values on CR concentration, this corre-
sponds to a ventricular permeability of approximately
3.4 μM hr−1. Although not statistically significant (P =
0.09), pWMH vb showed a moderate association (r
2 =
0.22) with the R1 increase observed midway through
the washout period (Figure 4a). An inverse association
(r2 = 0.31; P = 0.04) of pWMH vb with ventricular vol-
ume was also observed (Figure 4b).
Discussion
Our results demonstrate that the fractional blood vol-
ume of small WMHs in the deep, but not periventricular
WM, is decreased compared to NAWM in elderly indi-
viduals with minimal cardiovascular risk factors. While
reduced vb in the NAWM of individuals with and with-
out WMHs has been demonstrated by 15O-positron
emission tomography [51] and DSC MRI [48], the rela-
tive vb of WMHs and NAWM has been examined in
only a few studies. In migraine patients with larger (3–
21 mm diameter) though still focal dWMHs, the vb of
lesions was found by DSC MRI to be reduced compared
to NAWM, consistent with our results [44]. A similarFigure 3 Histograms of average CSF R1 values during CR washout. The mean (dashed line) and fitted Gaussian distribution (solid line) are also
shown. Time, t, was calculated as the temporal midpoint of each variable-TI image set. Data from one subject who completed only two post-CR
measurements were excluded.
intracranial volume (ICV). Error bars represent the SEM.
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the diffuse nature of lesions in these subjects combined
with the relatively poor spatial resolution makes compar-
isons more ambiguous [52]. However using the same
technique in a group of healthy elderly individuals all
between the ages of 85 and 86 years, Marstrand and col-
leagues were unable to find any significant reduction in
the vb of WMHs compared to NAWM [17]. Whether
such differences are truly absent in the very elderly brain
or were obscured by the corrections to their T2*-based
acquisition parameters necessary to obtain absolute vb
measurements or the more limited spatial resolution of
their images and subsequent partial volume effects, re-
mains to be seen.
The absolute reduction in the vb of dWMHs compared
to pWMHs approached 25% in the present study. While
confidence limits were too wide to establish the statis-
tical significance of this finding (due at least in part be-
cause of small subject numbers), the magnitude of the
difference suggests that alterations in blood–brain bar-
rier permeability and/or decreased capillary density may
be an important feature of lesion pathogenesis in the
deep WM. In contrast, changes in capillary permeability
appear to contribute relatively little to pWMH forma-
tion. Indeed, the microvascular defects and reduced ca-
pillary density frequently observed by histology in small
dWMHs are generally not seen in early pWMHs [53].
Instead, hyperintense caps and pencil-thin periventricu-
lar linings are most commonly seen in association with a
disrupted ependyma, presumably driven by abnormal os-
motic pressure gradients or as a compensatory mechanism
for the atrophic changes and ventricular enlargement that
accompany normal aging [54]. Our findings of a signifi-
cant inverse association between pWMH vb and ventricu-
lar volume combined with the association of CSF [CR]
and dilation of pWMH vessels are in accord with these
findings. It is also possible that age-related or ischemic
changes in the blood-CSF barrier may contribute to for-
mation of pWMHs. Changes in the blood-CSF barrier are
known to occur with age and cerebrovascular compromise
and could explain the increased R1 values in the CSF [55].
However, since paracellular diffusion of relatively large
molecular weight molecules (gadoteridol MW >500 Da) is
likely to be minimal and transcellular mechanisms of CR
transport across the blood CSF barrier unknown, add-
itional experiments, ideally with increased temporal reso-
lution in both the early and long times after CR
administration, will be necessary to examine the role of
the blood CSF barrier in pWMH formation more closely.
To our knowledge, the present study is the first to de-
termine the absolute vb of WMHs using relaxographic
imaging. Our use of a T1- rather than T2*- based ap-
proach minimizes the systematic errors caused by bulk
magnetic susceptibility effects which can degrade vbestimates based on T2*-weighted images [56]. However,
T1-based approaches typically suffer from low SNR and
reduced detectability of CR. To increase the sensitivity
of our measurements, all imaging was done at 7 T,
where the SNR in WM is ca. 50% higher than at 4 T and
the contrast to noise ratio is substantially increased
[41,57]. The former results in improved detection of
small lesions while the latter provides increased CR de-
tection sensitivity and accuracy of R1 measurements. To
further improve the accuracy of vb estimates, R1 changes
were fit to a pharmacokinetic model that incorporates
the effects of transendothelial water exchange on the
MR signal. Failure to account for exchange effects can
result in large errors in vb estimates, particularly in the
early stages of lesion formation when vascular distur-
bances are expected to be small [58]. The model also as-
sumes negligible leakage of CR from the vessels and a
fixed rate of water exchange across the capillary walls.
Such assumptions are reasonable in the healthy aged
WM, where vascular changes are expected to be subtle.
The extent to which they remain equally valid in both
deep and pWMHs, though, remains unclear. Bolus
tracking (dynamic contrast enhanced) MRI studies with
increased temporal resolution are currently underway to
examine the validity of these assumptions in both more
closely.
Our results provide in vivo evidence that permeability
changes in the blood–brain barrier are likely to accom-
pany formation of dWMHs, while extravascular changes
at the CSF-tissue interface may play a more important
role in pWMH formation. However, our study is not
without limitations. First, to minimize secondary effects
of chronic ischemia, we excluded individuals with major
cardiovascular risk factors. However, cognitive impair-
ment was not an exclusion criterion and, although mild,
was present in half of the study subjects. While the vb of
neither the NAWM nor WMHs was significantly differ-
ent in these subjects, we did not measure cerebral blood
flow. As a result, it is difficult to know to what extent
our conclusions are affected by the hypoperfusion and
altered cerebral autoregulation frequently associated
with cognitive decline [59]. Second, the pharmacokinetic
model upon which our estimates are based assumes that
CR remains in the blood throughout the measurement
period. If leakage into the extravascular space becomes
significant, errors in vb estimates can be substantial [36].
While CR extravasation across a relatively intact blood–
brain barrier is likely to be minimal in the deep WM, a
similar assumption in periventricular regions, where CR
in the CSF may exchange with interstitial fluid at a dis-
rupted ependymal lining, is less clear. As a result, the
pathobiological basis of vb associations in these regions
should be interpreted with caution. Third, the validity of
our findings depends on the accurate segmentation of
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netic field strength provide excellent conspicuity of small
WM lesions, quantitative segmentation of WMHs re-
mains challenging. Semiautomatic methods, like the one
used here, rely on placement of a ‘seed point’ and propa-
gation of the seeds to neighboring slices. The approach
eliminates the need for manual outlining and reduces
rater bias and error [60]. Nevertheless, results can be
strongly dependent on the exact location of the seed
point, as evidenced by an inter-rater agreement of se-
lected pixels of only 80%. To reduce false positives, only
those pixels identified as WMHs by both raters were in-
cluded in our analyses. While this approach likely de-
creases the specificity of segmentation results, it
provides an important increase in their sensitivity and
the validity of WMH measurements. Fourth, the accur-
acy of R1 values determined from signal intensity
changes in variable-TI datasets, and upon which vb esti-
mates rely, is made difficult by the complexity of the
MPRAGE sequence [32]. To minimize these errors and
improve the accuracy of R1 values, we used a fitting rou-
tine that models all the RF pulses, recovery periods and
the approach to steady state magnetization assuming a
constant flip angle across all imaging planes. However,
we did not correct for RF inhomogeneities in the images
which can be substantial at high field, particularly in
central brain regions [57]. While the non-selective na-
ture of the RF pulses and 3D image encoding make the
MPRAGE sequence relatively insensitive to these inho-
mogeneities, they remain a potential source of R1 inac-
curacies in our data. Finally, 3D relaxography, like all
quantitative MRI, requires a balance between spatial and
temporal resolution. To achieve the spatial resolution
sufficient for identification of small WMHs, each
variable-TI MPRAGE dataset required a scan times of
almost 15 minutes. In agreement with measurements at
3 Tesla [61], the accuracy of the R1 values obtained by
this method is quite good; however, the precision of vb
estimates would likely be increased with additional sam-
pling frequency.
Conclusions
Our findings suggest that in the absence of major vascu-
lar risk factors, the fractional blood water in WMHs is
increased compared to NAWM in the healthy aged
brain. While blood–brain barrier disturbances appear to
be a prominent feature of WMHs in the deep WM, dis-
turbances in the brain-CSF interface may play a more
important role in the etiology of pWMHs.
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